Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999

Morbidity and Mortality Weekly Report

Volumn 48, Issue 51-52, 2000, Pages 1165-1167

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

BACTEREMIA; FEMALE; HUMANS; ILLINOIS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 0034614298     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Herold B, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279: 593-8.
2. CDC. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR 1999;48:707-10.
3. CDC. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR 1997;46:624-6
4. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493-501.
5. Rotun SS, McMath V, Schoonamker DJ, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 1999; 5:147-9.
6. CDC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR 1997;46:626-8,656.
7. National Committee for Clinical Laboratory Standards. Approved standard M7-A4: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
8. CDC. Laboratory capacity to detect antimicrobial resistance, 1998. MMWR 2000;48:1167-71.